Akt-Induced Phosphorylation of N-CoR at Serine 1450 Contributes to Its Misfolded Conformational Dependent Loss (MCDL) in Acute Myeloid Leukemia of the M5 Subtype-Reference-Cited by-同舟云学术

Akt-Induced Phosphorylation of N-CoR at Serine 1450 Contributes to Its Misfolded Conformational Dependent Loss (MCDL) in Acute Myeloid Leukemia of the M5 Subtype

Published:2013-08-05 Issue:8 Volume:8 Page:e70891
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Nin Dawn Sijin,Ali Azhar Bin,Okumura Koichi,Asou Norio,Chen Chien-Shing,Chng Wee Joo,Khan Matiullah

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference57 articles.

1. Transcription Factors in myeloid development: balancing differentiation with transformation;F Rosenbauer;Nature Reviews: Immunology,2007

2. Contribution of oncogenes and tumor suppressor genes to myeloid leukemia;L Wolff;Biochim Biophys Acta,1997

3. Expression and regulation of myeloid-specific genes in normal and leukemic myeloid cells;M Lubbert;Blood,1991

4. A complex containing N-CoR, mSin3 and histone deacetylase mediates transcriptional repression;T Heinzel;Nature,1997

5. Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor;A Hörlein;Nature,1995

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Oral arsenic administration to humanized UDP-glucuronosyltransferase 1 neonatal mice induces UGT1A1 through a dependence on Nrf2 and PXR;Journal of Biological Chemistry;2023-03

2. Autophagic Degradation of Misfolded Nuclear Receptor Co-repressor (NCoR) Is Linked to the Growth of Tumor Cells in HBX Positive Hepatocellular Carcinoma (HCC);Frontiers in Oncology;2019-12-03

3. Ubiquitin specific protease 19 involved in transcriptional repression of retinoic acid receptor by stabilizing CORO2A;Oncotarget;2016-04-25

4. Misfolded N-CoR is Linked to the Ectopic Reactivation of CD34/Flt3-Based Stem-Cell Phenotype in Promyelocytic and Monocytic Acute Myeloid Leukemia;Frontiers in Oncology;2015-10-07